Following a string of customer…
Following a string of customer complaints, a Form 483 and [...]
About two years ago, a…
About two years ago, a head-to-head progression-free survival win made [...]
The new business unit is centered…
The new business unit is centered on four core capabilities, [...]
RNA-based vaccines and…
RNA-based vaccines and therapeutics may have faced a bumpy road [...]
As part of the MFN drug pricing…
As part of the MFN drug pricing deal the Trump [...]
After losing Bristol Myers Squibb…
After losing Bristol Myers Squibb as a client, Cellares continues [...]
Novartis appears to have broken…
Novartis appears to have broken the curse of the BTK [...]
This podcast feature a fireside…
This podcast feature a fireside chat between Dr Ira Mellman, [...]
Jazz Pharmaceuticals has added a…
Jazz Pharmaceuticals has added a second overall survival win to [...]
Late August has been rough for IV…
Late August has been rough for IV solution makers as [...]